JI-101 is an orally active multi-kinase inhibitor. JI-101 inhibits EphB4 , VEGFR-2 and PDGFR-β . JI-101 exhibits anticancer activity. JI-101 can be used in research related to ovarian cancer .
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Ovarian Cancer | Products > Disease Areas > Urogenital Cancer | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Ephrin Receptor | Products > Signaling Pathways > PDGFR | Products > Signaling Pathways > VEGFR
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.